Welcome to the August edition of The Breakthrough, our monthly newsletter that highlights the latest content on Pfizer's website. This month we’re covering our efforts to make clinical trials more patient-centric, what you need to know about Lyme disease, the different ways migraine affects the genders, and more.
Â
Pfizer has long strived to put patients at the center of our efforts to make breakthroughs, and this month we’re shining a spotlight on how we've brought that philosophy to our clinical trials. We spoke to three experts about improving access, optimizing the patient experience, and sharing back patient data once they’ve completed the clinical trials process. Hear what they had to say in this month’s featured article.
Â
We’ve still got a month of summer to go and if you plan to spend it outside, you should read our new piece on the risks of Lyme Disease, and how climate change is contributing to an increase in cases. Over the past quarter-century, they've more than doubled. Here are five things you need to know about Lyme Disease.
Â
You probably already know a little something about migraine, even if you don’t suffer from it, but did you know that there are stark differences in how men and women endure and cope with this condition? A new survey from the National Headache Foundation breaks down those differences. Check it out.
Â
Summer is full of celebrations, and on June 19th, Pfizer colleagues around the country held several of their own in recognition of Juneteenth. From the northeast to the Pacific northwest, Pfizer’s Global Black Community colleague resource group showed out with a bevy of employee-led events. Experience the joy.
Â
Last but not least, we have another monthly round-up of all the social media activity across Pfizer’s channels in July. Posts on LinkedIn, Instagram, and TikTok highlighted our interns’ summer experiences, showcases our volunteer efforts around Pfizer’s 175 Days of Good, and more. Catch up!Â
Â
Thanks for reading! Â
Â
Â